Endocrine Therapies in ER-Positive/HER2-Negative MBC: Understanding Their Benefits and Limitations to Optimize Treatment Selection Authors: Joyce A. O’Shaughnessy, MD; Aditya Bardia, MD, MPH, FASCO

https://www.medscape.org/viewarticle/1003008?sso=true&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_251222-OUS-HONC-1003008-cta